Kleanthis Xanthopoulos News
Most Popular Kleanthis Xanthopoulos Story
GSK tests the miRNA waters with $600M deal
Further solidifying RNA's "next big thing" status, GlaxoSmithKline and Regulus... Read more...
Latest Headlines
- April 17, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
